MedTrace Logo

Effect of Upstream High Bolus Dose of Tirofiban in Primary PCI for the Patients With STEMI on Short Term Outcome

NCT04111289 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2019-10-01

No results posted yet for this study

Summary

The goal of the study to investigate the impact of upstream HBD of Tirofiban on short outcome of STEMI patient.

Conditions

  • High Bolus Dose of Tirofiban

Interventions

DRUG

-Administration of tirofiban (25 ug/kg bolus and 0.15 ug/kg/min maintenance infusion)

* After consenting for primary PCI ,the patient will be assigned to one arm ( either upstream high bolus dose IV before going to cath lab or selective downstream administration according to operator discretion ) * Administration of tirofiban (25 ug/kg bolus and 0.15 ug/kg/min maintenance infusion) * Randomization will be performed by Microsoft Excel where random order will be generated for the study population

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Eman Qaood · Assiut University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-01
Primary Completion
2021-09-30
Completion
2022-01-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04111289 on ClinicalTrials.gov